3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
45
Neoplasm Metastasis
5
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms, Castration-Resistant
2
Ovarian Neoplasms
2
Metastatic Castration-Resistant Prostate Cancer
2
Melanoma
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Bulbo-Spinal Atrophy, X-Linked
2
Bites and Stings
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Salivary Gland Neoplasms
1
Prostate Cancer Metastatic Disease
1
Prostate Adenocarcinoma
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Hormone-Sensitive Prostate Cance
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Interventions
Cyclophosphamide
8
Methotrexate
6
ponatinib
5
fludarabine phosphate
5
merphos
4
Whole-Body Irradiation
4
Tacrolimus
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cytarabine
3
CT-P10
3
Busulfan
3
letermovir
2
blinatumomab
2
Vincristine
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Melphalan
2
Cyclosporine
2
venetoclax
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
bosutinib
1
auricularum
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
abiraterone
×
1 year
×
Clear all
No trials found.